Epidemiological Characteristics and Prevention Methods of Blisters in Ultra-trail Runners
NCT ID: NCT05071651
Last Updated: 2021-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2021-04-06
2021-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
SECONDARY OBJECTIVES :
To evaluate :
* The main locations of blisters.
* The severity of blisters
* The effectiveness of prevention methods To evaluate the incidence of blisters in an ultra-trail context.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Prevention of Thromboembolic Disease in Patients With a Lower Limb Trauma, Non Surgical, in Winter Sports Resort
NCT01303523
Trail Sciences Clecy: Markers of Performances
NCT05538442
Value of Ankle Pressure Index After Maximal Exercise Tests
NCT01812343
Fitness- and Health-related Effects of a Sports Injury Prevention Program in Competitive Alpine Skiers
NCT04021576
Effect of the Interaction Between the Type of Artificial Turf and Boots Model of Bone Health in Children Soccer Players
NCT02399553
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Prevention methods used before an ultra-trail via a self-questionnaire
SECONDARY JUDGING CRITERIA : Location of blisters, via a self-questionnaire Presence or not of blisters at the end of the ultra-trail or at the time of abandonment
STUDY SCHEME : Post-race questioning
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de Formation et de Recherche en Médecine de Montagne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Corentin Tanné, MD
Role: PRINCIPAL_INVESTIGATOR
Institut de Formation et de Recherche en Médecine de Montagne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ifremmont
Chamonix, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Blisters-stop 1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.